Literature DB >> 22348662

Differential regulation of monocyte cytokine release by αV and β(2) integrins that bind CD23.

Adrienne L Edkins1, Gillian Borland, Mridu Acharya, Richard J Cogdell, Bradford W Ozanne, William Cushley.   

Abstract

The human soluble CD23 (sCD23) protein displays highly pleiotropic cytokine-like activity. Monocytic cells express the sCD23-binding integrins αVβ(3), αVβ(5), αMβ(2) and αXβ(2), but it is unclear which of these four integrins most acutely regulates sCD23-driven cytokine release. The hypothesis that ligation of different sCD23-binding integrins promoted release of distinct subsets of cytokines was tested. Lipopolysaccharide (LPS) and sCD23 promoted release of distinct groups of cytokines from the THP-1 model cell line. The sCD23-driven cytokine release signature was characterized by elevated amounts of RANTES (CCL5) and a striking increase in interleukin-8 (IL-8; CXCL8) secretion, but little release of macrophage inflammatory protein 1β (MIP-1β; CCL4). Antibodies to αVβ(3) or αXβ(2) both promoted IL-8 release, consistent with the sCD23-driven pattern, but both also evoked strong MIP-1β secretion; simultaneous ligation of these two integrins further increased cytokine secretion but did not alter the pattern of cytokine output. In both model cell lines and primary tissue, integrin-mediated cytokine release was more pronounced in immature monocyte cells than in mature cells. The capacity of anti-integrin monoclonal antibodies to elicit a cytokine release response is epitope-dependent and also reflects the differentiation state of the cell. Although a pattern of cytokine release identical to that provoked by sCD23 could not be elicited with any individual anti-integrin monoclonal antibody, αXβ(2) and αVβ(3) appear to regulate IL-8 release, a hallmark feature of sCD23-driven cytokine secretion, more acutely than αMβ(2) or αVβ(5).
© 2012 The Authors. Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22348662      PMCID: PMC4489923          DOI: 10.1111/j.1365-2567.2012.03576.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  52 in total

1.  Hyper IgE in New Zealand black mice due to a dominant-negative CD23 mutation.

Authors:  Graham Lewis; Eleni Rapsomaniki; Tiphaine Bouriez; Tanya Crockford; Helen Ferry; Robert Rigby; Timothy Vyse; Teresa Lambe; Richard Cornall
Journal:  Immunogenetics       Date:  2004-10-19       Impact factor: 2.846

2.  Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia.

Authors:  John C Byrd; Thomas J Kipps; Ian W Flinn; Januaro Castro; Thomas S Lin; William Wierda; Nyla Heerema; James Woodworth; Steve Hughes; Shabnam Tangri; Sarah Harris; Dee Wynne; Arturo Molina; Bryan Leigh; Susan O'Brien
Journal:  Blood       Date:  2009-10-20       Impact factor: 22.113

3.  Stepwise in vitro affinity maturation of Vitaxin, an alphav beta3-specific humanized mAb.

Authors:  H Wu; G Beuerlein; Y Nie; H Smith; B A Lee; M Hensler; W D Huse; J D Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18.

Authors:  S Lecoanet-Henchoz; J F Gauchat; J P Aubry; P Graber; P Life; N Paul-Eugene; B Ferrua; A L Corbi; B Dugas; C Plater-Zyberk
Journal:  Immunity       Date:  1995-07       Impact factor: 31.745

5.  CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes.

Authors:  P Björck; C Elenström-Magnusson; A Rosén; E Severinson; S Paulie
Journal:  Eur J Immunol       Date:  1993-08       Impact factor: 5.532

6.  Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo.

Authors:  C Plater-Zyberk; J Y Bonnefoy
Journal:  Nat Med       Date:  1995-08       Impact factor: 53.440

7.  Increased levels of sCD23 in rheumatoid arthritis are related to disease status.

Authors:  A S Bansal; A J MacGregor; R S Pumphrey; A J Silman; W E Ollier; P B Wilson
Journal:  Clin Exp Rheumatol       Date:  1994 May-Jun       Impact factor: 4.473

8.  Negative feedback regulation of IgE synthesis by murine CD23.

Authors:  P Yu; M Kosco-Vilbois; M Richards; G Köhler; M C Lamers
Journal:  Nature       Date:  1994-06-30       Impact factor: 49.962

9.  The structure of human CD23 and its interactions with IgE and CD21.

Authors:  Richard G Hibbert; Peter Teriete; Gabrielle J Grundy; Rebecca L Beavil; Rajko Reljic; V Michael Holers; Jonathan P Hannan; Brian J Sutton; Hannah J Gould; James M McDonnell
Journal:  J Exp Med       Date:  2005-09-19       Impact factor: 14.307

10.  A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin.

Authors:  B E Vogel; S J Lee; A Hildebrand; W Craig; M D Pierschbacher; F Wong-Staal; E Ruoslahti
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

View more
  1 in total

Review 1.  Antibody-based immunotherapy of solid cancers: progress and possibilities.

Authors:  Christopher F Nicodemus
Journal:  Immunotherapy       Date:  2015-08-28       Impact factor: 4.196

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.